Scroll for Important Safety Information and Indication
IMPORTANT SAFETY INFORMATION
When you try to quit smoking, with or without CHANTIX,
you may have symptoms that may be due to nicotine
withdrawal, including urge to smoke, depressed mood,
trouble sleeping, irritability, frustration, anger, feeling
anxious, difficulty concentrating, restlessness,
decreased heart rate, and increased appetite or weight
gain. Some people have even experienced suicidal
thoughts when trying to quit smoking without medication.
Sometimes quitting smoking can lead to worsening of
mental health problems that you already have, such as
depression.
Some people have had serious side effects while taking
CHANTIX to help them quit smoking, including new or
worse mental health problems, such as changes in
behavior or thinking, aggression, hostility, agitation,
depressed mood, or suicidal thoughts or actions. These
symptoms happened more often in people who had a
history of mental health problems before taking
CHANTIX, than in people without a history of mental
health problems. Stop taking CHANTIX and call your
healthcare provider right away if you, your family, or
caregiver notice any of these symptoms. Before taking
CHANTIX, tell your healthcare provider if you have ever
had depression or mental health problems.
Some people had seizures during treatment with
CHANTIX. Most cases happened during the first month
of treatment. Tell your doctor if you have a history of
seizures. If you have a seizure during treatment with
CHANTIX, stop taking CHANTIX and contact your
healthcare provider right away.
Decrease the amount of alcohol you drink while taking
CHANTIX until you know if CHANTIX affects your ability
to tolerate alcohol. Some people experienced increased
drunkenness, unusual or sometimes aggressive
behavior, or memory loss of events while consuming
alcohol during treatment with CHANTIX.
Sleepwalking can happen with CHANTIX, and can
sometimes lead to behavior that is harmful to you or
other people, or to property. Stop taking CHANTIX and
tell your doctor if you start sleepwalking.
Do not take CHANTIX if you have had a serious allergic
or skin reaction to CHANTIX. Some people can have
serious skin reactions while taking CHANTIX, some of
which can become life-threatening. These can include
rash, swelling, redness, and peeling of the skin. Some
people can have allergic reactions to CHANTIX, some of
which can be life-threatening and include: swelling of the
face, mouth, and throat that can cause trouble breathing.
If you have these symptoms or have a rash with peeling
skin or blisters in your mouth, stop taking CHANTIX and
get medical attention right away.
Before starting CHANTIX, tell your doctor if you have a
history of heart or blood vessel problems. If you have
new or worse heart or blood vessel symptoms during
treatment, tell your doctor. Get emergency medical help
right away if you have any symptoms of a heart attack or
stroke.
The most common side effects of CHANTIX include
nausea (30%), sleep problems, constipation, gas and/or
vomiting. If you have side effects that bother you or don’t
go away, tell your doctor. You may have trouble
sleeping, vivid, unusual or strange dreams while taking
CHANTIX. Use caution driving or operating machinery
until you know how CHANTIX may affect you.
CHANTIX should not be taken with other quit-smoking
products. You may need a lower dose of CHANTIX if
you have kidney problems or get dialysis.
Before starting CHANTIX, tell your doctor if you are
pregnant, plan to become pregnant, or if you take
insulin, asthma medicines or blood thinners. Medicines
like these may work differently when you quit smoking.
What is CHANTIX?
CHANTIX is a prescription medication that, along with
support, helps adults 18 and over stop smoking. You
may benefit from quit-smoking support programs and/or
counseling during your quit attempt. It's possible that you
might slip up and smoke while taking CHANTIX. If you
do, you can stay on CHANTIX and keep trying to quit.
Please see full Prescribing Information, including
Medication Guide.
PP-CHM-USA-1541-02    © 2017 Pfizer Inc.    All rights reserved.